22nd European Workshop for Rheumatology Research, Leiden, The Netherlands, 28 February–3 March 2002
1 The Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College School of Science, Technology and Medicine, London, UK
2 Nikolaus Fiebiger Center for Molecular Medicine, University of Erlangen, Department of Medicine III, Erlangen, Germany
Arthritis Res 2002, 4:276-279 doi:10.1186/ar418Published: 14 May 2002
The European Workshop for Rheumatology Research met this year in Leiden, The Netherlands. The Workshop provided a platform to feast on new technologies and how they have taken research programmes forward. While there will be the inevitable delay during which mechanisms are devised for analysing the huge amount of information generated by these technologies, there is a lot already to look forward to. Highlights included genomic, reverse genomic and proteomic approaches to understanding disease pathogenesis and to identifying new therapeutic targets. Opportunities for exploring whether pharmacogenomics has a place in the clinic are now a reality, and phage display technology has been applied to in vivo arthritis models to identify human synovial microvascular 'post codes'.